Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FX1YB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,327
Award facts
- Contract value 100% obligated
- $57,326.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $57,326.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Keytruda 100 mg/4 mL vials. The contract, issued on June 18, 2025, with completion targeted for July 11, 2025, represents a specific fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. This delivery order was not subject to any set-aside designation, and performance will occur at the vendor's facility in Park Ridge, Illinois. The award demonstrates the company's continued role as a critical pharmaceutical supplier to the Department of Defense healthcare system.
DMS Pharmaceutical Group Inc. maintains a significant position within the federal pharmaceutical supply chain through its $500 million Indefinite Delivery Contract with the Defense Logistics Agency, valid through November 2026. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities nationwide. This particular delivery order for Keytruda, an oncology treatment, exemplifies the breadth of specialty pharmaceutical products the vendor supplies to support medical needs across Department of Defense healthcare sites. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group has established a robust portfolio of pharmaceutical product deliveries to federal agencies.
Quick answers
Who was awarded contract SPE2DB25FX1YB?
SPE2DB25FX1YB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FX1YB worth?
The government has obligated $57,327 on SPE2DB25FX1YB.
Is contract SPE2DB25FX1YB an order under another contract?
Yes. SPE2DB25FX1YB is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1YB competed?
The extent of competition for SPE2DB25FX1YB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award